Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flamel Technologies SA (NASDAQ:FLML)

10.69
Delayed Data
As of May 26
 +0.14 / +1.33%
Today’s Change
7.56
Today|||52-Week Range
26.09
-12.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$440.9M

Company Description

Flamel Technologies SA is a specialty pharmaceutical company with drug delivery and formulation expertise. It engages in the development, manufacture, and marketing of pharmaceutical products. The company operates under the following trademarks: Bloxiverz, DeliVax, Flamel Technologies, LiquiTime, Micropump, Medusa, Trigger Lock and Vazculep. Flamel Technologies was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Contact Information

Flamel Technologies SA
33, avenue du Dr. Georges Lévy
Vénissieux Rhone-alpes 69200
P:(347) 278-3434
Investor Relations:

Employees

Shareholders

Other institutional37.02%
Mutual fund holders31.15%
Individual stakeholders--

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Michael F. KananChief Financial Officer & Senior Vice President
Christian KalitaChief Pharmacist, Director-Quality & Regulatory
David MonteithVice President-Research & Development
Phillandas T. ThompsonSenior Vice President & General Counsel